DOI QR코드

DOI QR Code

Survival Analysis of Patients with Gastric Cancer Undergoing Surgery at the Iran Cancer Institute: A Method Based on Multi-State Models

  • Zare, Ali (Department of Epidemiology and Biostatistics, Iran, Tehran University of Medical Sciences) ;
  • Mahmoodi, Mahmood (Department of Epidemiology and Biostatistics, Iran, Tehran University of Medical Sciences) ;
  • Mohammad, Kazem (Department of Epidemiology and Biostatistics, Iran, Tehran University of Medical Sciences) ;
  • Zeraati, Hojjat (Department of Epidemiology and Biostatistics, Iran, Tehran University of Medical Sciences) ;
  • Hosseini, Mostafa (Department of Epidemiology and Biostatistics, Iran, Tehran University of Medical Sciences) ;
  • Naieni, Kourosh Holakouie (Department of Epidemiology and Biostatistics, Iran, Tehran University of Medical Sciences)
  • Published : 2013.11.30

Abstract

Background: Gastric cancer is one of the most common causes of cancer deaths all over the world and the most important reason for its high rate of death is its belated diagnosis at advanced stages of the disease. Events occur in patients which are regarded not only as themselves factors affecting patients' survival but also which can be affected by other factors. This study was designed and implemented aiming to identify these events and to investigate factors affecting their occurrence. Materials and Methods: Data from 330 patients with gastric cancer undergoing surgery at the Iran Cancer Institute from 1995-1999 were analyzed. The survival time of these patients was determined after surgery and the effects of various factors including demographic, diagnostic and clinical as well as medical, and post-surgical varuiables on the occurrence of death hazard without relapse, hazard of relapse, and death hazard with a relapse were assessed. Results: The median survival time for these patients was 16.3 months and the 5-year survival rate was 21.6%. Based on the results of multi-state model, age and distant metastases affected relapse whereas disease stage, type and extent of surgery, lymph nodes metastases, and number of renewed treatments affected death hazard without relapse. Moreover, age, type and extent of surgery, number of renewed treatments, and liver metastases were identified as factors affecting death hazard in patients with relapse. Conclusions: Most cancer studies pay heed to factors which have effect on death occurrence, but some events occur which should be taken into consideration to better describe the natural process of the disease and provide researchers with more accurate data.

Keywords

Gastric cancer;intermediate event;multi-state model;proportional hazards model;survival rate

References

  1. Adachi Y, Tsuchihashi J, Shiraishi N, et al (2003). AFP-producing gastric carcinoma: multivariate analysis of prognostic factors in 270 patients. Oncol, 65, 95-101. https://doi.org/10.1159/000072332
  2. Akbari ME, Fattahi F, Afsharfard A, et al (2009). Survival rate of gastric cancer in Iran. J Res Med Sci, 14, 367.
  3. Andersen PK (1988). Multistate models in survival analysis: a study of nephropathy and mortality in diabetes. Stat Med, 7, 661-70. https://doi.org/10.1002/sim.4780070605
  4. Andersen PK (1993). Statistical models based on counting processes: Springer.
  5. Andersen PK, Keiding N (2002). Multi-state models for event history analysis. Stat Methods Med Res, 11, 91-115. https://doi.org/10.1191/0962280202SM276ra
  6. Biglarian A, Hajizadeh E, Kazemnejad A, Zali M (2009). Survival analysis of gastric cancer patients using Cox model: a five year study. Tehran University Medical Journal (TUMJ), 67.
  7. Buonadonna A, Lombardi D, De Paoli A, Bidoli E, Frustaci S (2003). Adenocarcinoma of the stomach: univariate and multivariate analyses of factors associated with survival. Suppl Tumori, 2, 31-4.
  8. Chau I, Norman AR, Cunningham D, et al (2004). Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer-pooled analysis from three multicenter, randomized, controlled trials using individual patient data. J Clin Oncol, 22, 2395-403. https://doi.org/10.1200/JCO.2004.08.154
  9. Collett D (2003). Modelling survival data in medical research: CRC press.
  10. Dehkordi BM, Tabatabaee H (2007). Modeling survival analysis in gastric cancer patients using the proportional hazards model of Cox. Iranian J Epidemiol, 3.
  11. Ding YB, Chen GY, Xia JG, et al (2004). Correlation of tumor-positive ratio and number of perigastric lymph nodes with prognosis of patients with surgically-removed gastric carcinoma. World J Gastroenterol, 10, 182-5. https://doi.org/10.3748/wjg.v10.i2.182
  12. Haidari M, Nikbakht MR, Pasdar Y, Najafi F (2012). Trend analysis of gastric cancer incidence in Iran and its six geographical areas during 2000-2005. Asian Pac J Cancer Prev, 13, 3335-41. https://doi.org/10.7314/APJCP.2012.13.7.3335
  13. Kalbfleisch JD, Prentice RL (2011). The statistical analysis of failure time data: John Wiley and Sons.
  14. Kay R (1986). A Markov model for analysing cancer markers and disease states in survival studies. Biometrics, 42, 855-65. https://doi.org/10.2307/2530699
  15. Klein JP, Moeschberger ML (2003). Survival analysis: techniques for censored and truncated data: Springer.
  16. Maroufizadeh S, Hajizadeh E, Baghestani AR, Fatemi SR (2011). Multivariate analysis of prognostic factors in gastric cancer patients using additive hazards regression models. Asian Pac J Cancer Prev, 12, 901-7.
  17. Mohagheghi MA (2004). Annual report of Tehran cancer registery 1999: The cancer institute publication.
  18. Mohagheghi MA, Mosavi-Jarrahi A, Zeraati H (1998). Annual report of Tehran University of medical sciences district cancer registery 1997. Tehran: The cancer institute publication.
  19. Parkin D (1998). Epidemiology of cancer: global patterns and trends. Toxicol Lett, 102, 227-34.
  20. Pourhoseingholi M, Moghimi-Dehkordi B, Safaee A, et al (2009). Prognostic factors in gastric cancer using log-normal censored regression model. Indian J Med Res, 129, 262-7.
  21. Pourhoseingholi MA, Hajizadeh E, Moghimi Dehkordi B, et al (2007). Comparing cox regression and parametric models for survival of patients with gastric carcinoma. Asian Pac J Cancer Prev, 8, 412.
  22. Roshanaei G, Ghannad MS, Jafarabadi MA, Faradmal J, Sadighi S (2011). Prognostic impact of risk factors in patients with gastric cancer in Iran. Asian Pac J Cancer Prev, 12, 3005-8.
  23. Sadighi S, Raafat J, Mohagheghi M, Meemary F (2005). Gastric carcinoma: 5 year experience of a single institute. Asian Pac J Cancer Prev, 6, 195-6.
  24. Samadi F, Babaei M, Yazdanbod A, et al (2007). Survival rate of gastric and esophageal cancers in Ardabil province, North-West of Iran. Arch Iran Med, 10, 32-37.
  25. Schwarz RE, Zagala-Nevarez K (2002) Recurrence patterns after radical gastrectomy for gastric cancer: prognostic factors and implications for postoperative adjuvant therapy. Ann Surg Oncol, 9, 394-400. https://doi.org/10.1007/BF02573875
  26. Shiraishi N, Sato K, Yasuda K, Inomata M, Kitano S (2007) Multivariate prognostic study on large gastric cancer. J Surg Oncol, 96, 14-8. https://doi.org/10.1002/jso.20631
  27. Thong-Ngam D, Tangkijvanich P, Mahachai V, Kullavanijaya P (2001). Current status of gastric cancer in Thai patients. J Med Assoc Thailand, 84, 475-82.
  28. Triboulet J, Fabre S, Castel B, Toursel H (2001). Adenocarcinomas of the distal esophagus and cardia: surgical management. Cancer Radither, 5, 90-7. https://doi.org/10.1016/S1278-3218(01)80013-5
  29. Wang CS, Hsieh CC, Chao TC, et al (2002). Resectable gastric cancer: operative mortality and survival analysis. Chang Gung Med J, 25, 216-27.
  30. Yagi Y, Seshimo A, Kameoka S (2000). Prognostic factors in stage IV gastric cancer: univariate and multivariate analyses. Gastric Cancer, 3, 71-80. https://doi.org/10.1007/PL00011699
  31. Zeraati H, Mahmoodi M, Kazamnejad A, Mohammad K (2005a). Postoperative life expectancy life gastric cancer patients and its associated factors. Saudi Med J, 26, 1203-7.
  32. Zeraati H, Mahmoudi M, Kazemnejad A, Mohammad K (2005b). Postoperative survival in gastric cancer patients and its associated factors: a method based on a non-homogenous semi-markovian process. Int J Cancer Res, 1, 87-93. https://doi.org/10.3923/ijcr.2005.87.93
  33. Zeraati H, Mahmoudi M, Kazemnejad A, Mohammad K (2006). Postoperative survival in gastric cancer patients and its associated factors: A time dependent covariates model. Iranian J Public Health, 35.

Cited by

  1. Experimental Study on Sustained-release 5-Fluorouracil Implantation in Canine Peritoneum and Para-aortic Abdominalis vol.15, pp.1, 2014, https://doi.org/10.7314/APJCP.2014.15.1.407
  2. Factors Predicting Survival of Patients with Gastric Cancer vol.15, pp.14, 2014, https://doi.org/10.7314/APJCP.2014.15.14.5835
  3. Comparison of 2-Dimensional and 3-Dimensional Conformal Treatment Plans in Gastric Cancer Radiotherapy vol.15, pp.17, 2014, https://doi.org/10.7314/APJCP.2014.15.17.7401
  4. A Registry Program for Familial Gastric Cancer Patients Referred to Cancer Institute of Iran vol.15, pp.5, 2014, https://doi.org/10.7314/APJCP.2014.15.5.2141
  5. Inhibitory Effects of 3-Bromopyruvate on Human Gastric Cancer Implant Tumors in Nude Mice vol.15, pp.7, 2014, https://doi.org/10.7314/APJCP.2014.15.7.3175
  6. Assessing Misdiagnosis of Relapse in Patients with Gastric Cancer in Iran Cancer Institute Based on a Hidden Markov Multi-state Model vol.15, pp.9, 2014, https://doi.org/10.7314/APJCP.2014.15.9.4109
  7. Manganese Superoxide Dismutase (MnSOD Val-9Ala) Gene Polymorphism and Susceptibility to Gastric Cancer vol.16, pp.2, 2015, https://doi.org/10.7314/APJCP.2015.16.2.485
  8. IL-1B (C+3954T) Gene Polymorphism and Susceptibility to Gastric Cancer in the Iranian Population vol.16, pp.2, 2015, https://doi.org/10.7314/APJCP.2015.16.2.841